2 patients who achieved CR and had an HSCT have lived for +9-months since the abstract was announced on the 6th Nov 2023. Given the difficulty treating R/R AML and particularly the poor prognosis of these patients, that is a remarkable amount of added time to be in complete remission. I can't understand the complexity with receiving updates due to the situation on that side of the world, but if there is something to inform the market with, it should have happened.
- Forums
- ASX - By Stock
- Ann: Bisantrene Phase 2 AML Trial Successful Concludes
2 patients who achieved CR and had an HSCT have lived for...
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.49 |
Change
0.020(1.36%) |
Mkt cap ! $249.7M |
Open | High | Low | Value | Volume |
$1.48 | $1.49 | $1.46 | $60.58K | 41.16K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5448 | $1.49 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.54 | 2285 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5448 | 1.485 |
1 | 2500 | 1.480 |
1 | 1400 | 1.475 |
1 | 9188 | 1.470 |
1 | 1800 | 1.465 |
Price($) | Vol. | No. |
---|---|---|
1.535 | 2285 | 1 |
1.570 | 12928 | 2 |
1.575 | 2000 | 1 |
1.580 | 12717 | 2 |
1.600 | 100 | 1 |
Last trade - 12.26pm 13/11/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online